INVION SECURES RESEARCH ALLIANCE WITH HUDSON INSTITUTE OF MEDICAL RESEARCH ― Hudson Institute is a leading Australian biomedical research institute recognised internationally for delivering better health through research into cancer and inflammation
― The alliance is aimed at advancing Invion’s licenced cancer treatment technology,
PhotosoftTM
― Hudson Institute will provide research and clinical expertise on a series of projects in collaboration with Invion
― Projects will target a range of common and difficult to treat cancers, starting with ovarian cancer ― Invion’s development costs are financed by a non-dilutive funding agreement with The Cho Group
INVION SECURES RESEARCH ALLIANCE WITH HUDSON INSTITUTE OF...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $20.29M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $7.612K | 3.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 5729449 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 12383990 | 52 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IVX (ASX) Chart |
